We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$6.59B
AUM Growth
-$836M
(-11%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-17.84%
Top 10 Holdings %
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$18.4M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$15.6M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$15.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$15M |
| 5 |
Adobe
ADBE
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$23.1M |
| 2 |
Palo Alto Networks
PANW
|
+$20.9M |
| 3 |
Cigna
CI
|
+$16.5M |
| 4 |
Charter Communications
CHTR
|
+$15.8M |
| 5 |
Cytokinetics
CYTK
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.73% |
| 2 | Communication Services | 2.58% |
| 3 | Financials | 2.16% |
| 4 | Technology | 1.6% |
| 5 | Consumer Discretionary | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNET
1026
VNET Group
VNET
$2.06B
| $154K | ﹤0.01% |
+99,494
| New | +$184K |
|
|
VTNR
1027
CALL
DELISTED
Vertex Energy, Inc
VTNR
| $154K | ﹤0.01% |
110,000
| – | – |
|
|
AVDL
1028
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $152K | ﹤0.01% |
+9,000
| New | +$134K |
|
1029
CALL
ChargePoint
CHPT
$150M
| $150K | ﹤0.01% |
3,940
| – | – |
|
1030
PUT
Gevo
GEVO
$372M
| $146K | ﹤0.01% |
190,000
| – | – |
|
|
DEA
1031
Easterly Government Properties
DEA
$1.18B
| $138K | ﹤0.01% |
+4,800
| New | +$146K |
|
1032
Cemex
CX
$16.7B
| $135K | ﹤0.01% |
+15,000
| New | +$120K |
|
1033
CALL
Neuropace
NPCE
$467M
| $132K | ﹤0.01% |
+10,000
| New | +$143K |
|
1034
PUT
TeraWulf
WULF
$8.95B
| $132K | ﹤0.01% |
+50,000
| New | +$98.6K |
|
|
SCS
1035
CALL
DELISTED
Steelcase
SCS
| $131K | ﹤0.01% |
10,000
-30,000
| -75% | -$385K |
|
1036
Travere Therapeutics
TVTX
$5.92B
| $130K | ﹤0.01% |
+16,807
| New | +$142K |
|
|
AUTL
1037
Autolus Therapeutics
AUTL
$506M
| $128K | ﹤0.01% |
20,100
+16,341
| +435% | +$102K |
|
1038
PUT
PureCycle Technologies
PCT
$1.38B
| $124K | ﹤0.01% |
+20,000
| New | +$93.1K |
|
1039
PUT
Lifestance Health
LFST
$3.96B
| $123K | ﹤0.01% |
+20,000
| New | +$135K |
|
|
NKLA
1040
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $122K | ﹤0.01% |
3,903
-3,334
| -46% | -$71.6K |
|
|
OSG
1041
Octave Specialty Group
OSG
$256M
| $120K | ﹤0.01% |
7,700
-117,510
| -94% | -$1.85M |
|
1042
Kiniksa Pharmaceuticals
KNSA
$6.09B
| $118K | ﹤0.01% |
+6,000
| New | +$117K |
|
1043
Kopin
KOPN
$732M
| $116K | ﹤0.01% |
64,267
+6,840
| +12% | +$15.2K |
|
1044
Red Rock Resorts
RRR
$3.56B
| $114K | ﹤0.01% |
1,900
-28,600
| -94% | -$1.59M |
|
1045
Talkspace
TALK
$874M
| $113K | ﹤0.01% |
+31,654
| New | +$86.1K |
|
1046
Vir Biotechnology
VIR
$1.54B
| $111K | ﹤0.01% |
+10,925
| New | +$111K |
|
|
CIM
1047
Chimera Investment
CIM
$991M
| $111K | ﹤0.01% |
8,001
| – | – |
|
1048
Cheesecake Factory
CAKE
$5.24B
| $108K | ﹤0.01% |
3,000
-55,500
| -95% | -$1.93M |
|
|
1049
Gevo
GEVO
$372M
| $108K | ﹤0.01% |
141,005
+27,005
| +24% | +$23.5K |
|
1050
SoFi Technologies
SOFI
$23.5B
| $108K | ﹤0.01% |
+14,797
| New | +$118K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q1 2024 Portfolio in Review
As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Caption Management withdrew a net $1.17B in Q1 2024, closing 676 positions and reducing 294 holdings. Its most notable exit was Palo Alto Networks, an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.7% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Caption Management opened a new position in Adobe worth $11.5M.
- Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
- Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
- Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
- Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
- Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
- Caption Management opened 509 new positions and closed 676 in Q1 2024.
- Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.
Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.